[CANADA, English] Canada, Français

Menu

HomeHow to TakePossible Side EffectsFrequently Asked QuestionsResources
PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)


PAXLOVID is used in adults to treat mild-to-moderate coronavirus disease 2019 (COVID-19) in patients who:

  • Have a positive result from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral testing and
  • Have a high risk of getting severe COVID-19, including hospitalization or death.
 

PAXLOVID is NOT approved for any of the following: 

  • To treat patients who are hospitalized due to severe or critical COVID-19.
  • To prevent COVID-19.
  • To be used for longer than 5 days in a row.
  • For use in children and adolescents less than 18 years of age. 


Patients with kidney problems: Tell your healthcare professional before you take PAXLOVID if you have any kidney problems. You might need a lower dose of PAXLOVID. Your healthcare professional will prescribe a dose that is right for you. 
Serious interactions with other medicines: Many medicines interact with PAXLOVID. Taking PAXLOVID with these medicines may cause serious or life-threatening side effects. Tell your healthcare professional about all the medicines you take before you start taking PAXLOVID. 

 Patient medication information Learn how and when to take this medication
Product Expiration Date

Health Canada authorized the extension of the shelf-life for certain PAXLOVID packs. This means that your medication can still be used, even after the printed expiration date, which can be found on both the carton and the individual blister cards.

For further details, download the information sheet available in the Resources section. 

If you have a PAXLOVID pack with an expiration date listed on the middle column of the chart below, please see the right column to find the extended expiration date. 
 

Dose Pack  Lot #  Labelled Expiration Date*  Updated
Extended
Expiration Date* 









PAXLOVID (300 mg nirmatrelvir [2 x 150 mg]; 100 mg ritonavir) 		 FT3540 08/2022 07/2023
FX4437,
FX4444		 01/2023 07/2023 
FX8106  08/2023 
FX7185  09/2023 
GA6769,
GA6205, GA6761 		 02/2023  12/2023
GC2133, GC2886  01/2024 
GC8177  02/2024 
GD4585,
GC5723, GC5720 		 03/2023  01/2024 
GA3793, GD1181  11/2023
GD1183  02/2024 
GD4677,
GD8410,
GD8409,
GC8182,
GC8181 		 04/2023   03/2024 
GD8407,
GD4673,
GD4670,
GD4671,
GD4669,
GC5733,
GD4678 		 02/2024 
GG2189,
GG2190,
GG2191,
GG2187, GG2185 		 05/2023   03/2024 
GK4940,
GK4941, GK4942 		 11/2023  05/2024 
GK4943,
GJ2964,
GK1234,
GJ7300,
GJ7303,
GL0349,
GL6161,
GL0350,
GL0351,
GL0352, GJ2965 		 12/2023  03/2024 
GM7360,
GM7359,
GM7358, GM7357 		 01/2024  03/2024 
GR2928  05/2024


PAXLOVID (150 mg nirmatrelvir; 100 mg ritonavir) 		 GJ4599  03/2023  03/2024 
GG3564  05/2023  01/2024 
GP9562, GP9563  11/2023  05/2024 


* Note that the labelled expiration date is valid until the end of the month. 

​​​​​​​Who can take PAXLOVID?

PAXLOVID is used in adults to treat mild-to-moderate coronavirus disease 2019 (COVID-19) in patients who:

  • Have a positive result from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral testing and
  • Have a high risk of getting severe COVID-19, including hospitalization or death.
 

PAXLOVID is NOT approved for any of the following:

  • To treat patients who are hospitalized due to severe or critical COVID-19.
  • To prevent COVID-19.
  • To be used for longer than 5 days in a row.
  • For use in children and adolescents less than 18 years of age.
  •  


Patients with kidney problems: Tell your healthcare professional before you take PAXLOVID if you have any kidney problems. You might need a lower dose of PAXLOVID. Your healthcare professional will prescribe a dose that is right for you. 

Serious interactions with other medicines: Many medicines interact with PAXLOVID. Taking PAXLOVID with these medicines may cause serious or life-threatening side effects. Tell your healthcare professional about all the medicines you take before you start taking PAXLOVID. 

More informationHow to Take

Learn how and when to take this medicine

 Learn How Possible Side Effects

Learn about important possible side effects

 Learn More Frequently Asked Questions

Want to learn more? 

 Explore ​​​​​​​Answers

Pfizer is committed to ensuring that people have accurate information about the drug PAXLOVID, including how it is accessed and administered. 
 

For more
​​​​​​​information

For Medical Information, visit www.pfizermedicalinformation.ca or call
1-800-463-6001.
 

This material was developed by Pfizer, as part of the risk minimization plan for PAXLOVID. This material is not intended for promotional use.

This site is intended only for Canadian residents. The products discussed in this site may have different product labelling in different countries.
The information provided is for educational purposes only and is not intended to replace discussions with a healthcare professional.

Copyright © 2023 Pfizer Inc. All rights reserved. PP-PAX-CAN-0096-EN

Update Effective: October 3, 2023

PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)

Health Canada authorized the extension of the shelf-life for certain PAXLOVID packs. This means that your medication can still be used, even after the printed expiration date, which can be found on both the carton and the individual blister cards.  

Pfizer issued a correction to the extended expiration dates for PAXLOVID on June 14, 2023. Please refer only to the corrected expiration dates in the updated table below.
 

Dose Pack 

Lot #

Labelled Expiration Date* 

Updated Extended Expiration Date*

PAXLOVID (300 mg nirmatrelvir [2 x
150 mg]; 100 mg ritonavir) 

FT3540 

08/2022 

 07/2023 

FX4437, FX4444 

01/2023 

 07/2023 

FX8106 

 08/2023

FX7185  

 09/2023

GA6769, GA6205, GA6761 

02/2023 

12/2023

GC2133, GC2886 

01/2024

GC8177 

02/2024

GD4585, GC5723, GC5720 

03/2023 

01/2024 

GA3793, GD1181 

11/2023

GD1183 

02/2024

GD4677, GD8410, GD8409, GC8182, GC8181 

04/2023 

03/2024 

GD8407, GD4673, GD4670, GD4671, GD4669, GC5733, GD4678 

02/2024

GG2189, GG2190, GG2191, GG2187, GG2185 

05/2023 

03/2024 

GK4940, GK4941, GK4942 

11/2023 

03/2024 

GK4943, GJ2964, GK1234, GJ7300, GJ7303, GL0349, GL6161, GL0350, GL0351, GL0352, GJ2965 

12/2023 

03/2024 

GM7360, GM7359, GM7358, GM7357 

01/2024 

 03/2024 
 

GR2928 

 05/2024

PAXLOVID (150 mg nirmatrelvir; 100 mg ritonavir) 

GJ4599 

03/2023 

03/2024 

GG3564 

05/2023 

01/2024 

GP9562, GP9563 

11/2023 

05/2024 


* Note that the labelled expiration date is valid until the end of the month.